HSPA1A and breast cancer: The Hsp70-peptide complexes isolated from DCs fused to 4T1 murine BC cells were encapsulated in nanoliposomes to improve their bioavailability and antitumor immunity, resulting in an increase in the activation of T lymphocytes in BC, compared to the control variant (without liposomes) [167] (Table 2).